PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 29 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $252,000 | – | 25,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIFESA CAPITAL MANAGEMENT, LP | 125,000 | $1,258,000 | 0.64% |
| Wealthspring Capital LLC | 259,810 | $2,614,000 | 0.51% |
| Sage Rock Capital Management LP | 184,000 | $1,851,000 | 0.33% |
| Castle Creek Arbitrage, LLC | 400,000 | $4,024,000 | 0.20% |
| Shaolin Capital Management LLC | 750,000 | $7,545,000 | 0.19% |
| Schechter Investment Advisors, LLC | 160,650 | $1,616,000 | 0.15% |
| Yakira Capital Management, Inc. | 100,000 | $1,006,000 | 0.14% |
| MANGROVE PARTNERS IM, LLC | 199,900 | $2,011,000 | 0.11% |
| Spartan Fund Management Inc. | 50,000 | $629,000 | 0.10% |
| Silver Rock Financial LP | 46,243 | $465,000 | 0.09% |